logo
Measles creates panic across Americas & Europe, India sends 300,000 vaccine doses to Bolivia

Measles creates panic across Americas & Europe, India sends 300,000 vaccine doses to Bolivia

First Post4 days ago
Until last week, there were 98 active cases of measles in Bolivia as the country's government launched a door-to-door vaccination drive to curb the spread of the disease read more
India dispatched 300,000 doses of measles and rubella vaccine to Bolivia on Thursday as cases rise exponentially in the South American country. A measles outbreak is also rampant in the US and Europe.
'India dispatched a consignment of 300,000 doses of Measles & Rubella vaccines alongwith ancillary supplies to support Bolivia in managing the outbreak of the disease,' MEA Spokesperson Randhir Jaiswal said.
India dispatched a consignment of 300,000 doses of Measles & Rubella vaccines alongwith ancillary supplies to support Bolivia in managing the outbreak of the disease.
India stands by its friends in the Global South.
🇮🇳 🇧🇴 pic.twitter.com/RAur5mTNFb — Randhir Jaiswal (@MEAIndia) July 17, 2025
STORY CONTINUES BELOW THIS AD
Measles in Bolivia
Until last week, there were 98 active cases of measles in Bolivia as the country's government launched a door-to-door vaccination drive to curb the spread of the disease.
Health Minister María Renée Castro emphasised the urgency of the situation, stating that most infections were affecting children who had not received one or both doses of the immuniser.
She urged parents to ensure their children are fully vaccinated. 'Only two doses are needed to protect our children!' she stressed. 'We are working intensively in municipalities and departments, activating mobile vaccination brigades and early case detection,' she added.
Measles in the US and Europe
The US is currently witnessing its worst year of measles outbreak since 1992, as the country has recorded 1,288 cases so far, the highest in three decades, according to the latest figures from the Centres for Disease Control and Prevention (CDC).
More than two-thirds of states have reported at least one case, with 27 outbreaks (three or more related cases) identified nationwide. Three deaths have occurred, two unvaccinated children in Texas and one adult in New Mexico, with dozens hospitalised.
Similarly, the disease is spreading at an alarming rate in Europe, with at least one child dying last week in the UK's Liverpool.
Measles cases in the WHO's 53-country European region, which also includes nations in Central Asia, jumped from 60,756 in 2023 to 148,974 last year, according to data released Tuesday by the UN's global health agency.
STORY CONTINUES BELOW THIS AD
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Antimicrobial resistant superbugs could kill millions, cost $2 trillion yearly by 2050: Report
Antimicrobial resistant superbugs could kill millions, cost $2 trillion yearly by 2050: Report

Time of India

time5 hours ago

  • Time of India

Antimicrobial resistant superbugs could kill millions, cost $2 trillion yearly by 2050: Report

Representative AI-generated image Antimicrobial-resistant superbugs could lead to substantial global mortality and economic losses of approximately $2tn annually by 2050, according to a study, quoted by the Guardian. Analysis from a UK government-sponsored research reveals that rising antimicrobial resistance (AMR) could result in yearly global GDP losses of $1.7 trillion over the next 25 years without decisive intervention. The Center for Global Development's research indicates severe economic impact on the US, UK and EU economies. Recent reductions in aid funding appear counterproductive, particularly as the UK government has eliminated Fleming fund support for AMR prevention in developing nations. Similarly, the US has confirmed $9 billion in foreign aid reductions, with European nations following suit. Anthony McDonnell, who led the research at the Center for Global Development, explained that initial projections were based on historical resistance trends. He noted that significant aid reductions by the US (80%), UK (from 0.5% to 0.3% of GNI), France, and Germany could accelerate resistance rates to worst-case scenarios. He emphasised that no country, regardless of their AMR control success, should be complacent. Without protecting AMR programmes from funding cuts, global resistance rates could escalate to match severely affected nations, resulting in increased mortality worldwide and substantial economic consequences. The study, covering 122 countries, projects annual GDP losses by 2050 could reach $722 billion in China, $295.7 billion in the US, $187 billion in the EU, $65.7 billion in Japan, and $58.6 billion in the UK under pessimistic scenarios. The Institute for Health Metrics and Evaluation forecasts a 60% increase in AMR-related deaths by 2050, with annual mortality reaching 1.34 million in the US and 184,000 in the UK. Drug-resistant infections are expected to rise significantly. Antibiotic-resistant infections double treatment costs due to increased hospitalisations, extended stays, expensive alternative treatments, and complex care requirements. The research estimates global AMR treatment costs could rise by $176bn annually, with UK costs increasing from $900m to $3.7bn and US costs from $15.5bn to $57bn. The study indicates workforce reductions of 0.8% in the UK, 0.6% in the EU, and 0.4% in the US due to resistant infections. However, increased investment in addressing superbugs could boost annual economic growth by $156.2bn in the US and $12bn in the UK by 2050. Dr Mohsen Naghavi from IHME warned that without immediate action, current medicines might become ineffective, potentially making simple infections lethal, according to The Guardian. This requires governmental policy changes, new drug development, and public education about antibiotics' ineffectiveness against viruses. A UK government representative highlighted their 10-year health strategy addressing AMR, citing progress in reducing antibiotic use in meat production and developing new treatment incentives whilst maintaining international cooperation.

Superbugs could kill millions and trigger $2 trillion economic meltdown by 2050
Superbugs could kill millions and trigger $2 trillion economic meltdown by 2050

Time of India

time7 hours ago

  • Time of India

Superbugs could kill millions and trigger $2 trillion economic meltdown by 2050

A recent study highlights an impending global catastrophe: antimicrobial resistance threatens to claim millions of lives. By 2050, the global economy could suffer losses amounting to trillions of dollars. Major economies, including the US, UK, and China, are at risk of severe financial repercussions. Experts emphasize the urgent need for investments in innovative antibiotics and enhanced infection control measures. MRSA bacteria in a petri dish. The US, UK and EU economies are on course to be among those hardest hit by antimicrobial resistance. Photograph: Fabrizio Bensch/Reuters Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads By 2050, if the increase in antimicrobial resistance AMR ) is not stopped, superbugs could kill millions more people and cost the world economy around $2 trillion annually, according to new Centre for Global Development, a report supported by the UK government, cautions that rising AMR rates might deplete global GDP by $1.7 trillion a year over the next 25 read: Untreatable fungal infections are now killing nearly 3.8 mn each year, WHO experts sound alarm Economies such as the US, UK, and EU are projected to suffer some of the heaviest financial blows, leading critics to slam recent cuts to foreign aid budgets as short-sighted and harmful. Fleming Fund , aimed at AMR combatThese concerns follow the UK's recent decision to scrap funding for the Fleming Fund, a programme dedicated to combating AMR in lower-income nations. Similar aid reductions have been made by the US, which slashed its overseas aid by 80%, and various European to the study's worst-case scenarios, Anthony McDonnell, the principal author, cautioned that these aid cuts could hasten resistance rates worldwide. Even nations that are now efficiently handling the threat run the danger of seeing rising infection rates and death tolls in the absence of specialised AMR modelling, which examined the economic and health burden of AMR across 122 nations, forecasts stark worst-case scenario is that by 2050, China's yearly GDP losses might amount to $722 billion, the US $295.7 billion, the EU $187 billion, Japan $65.7 billion, and the UK $58.6 read: AI stuns scientists : Superbug mystery solved in 48 hours after decade long research According to data from the Institute for Health Metrics and Evaluation (IHME), the number of deaths from AMR is expected to increase by 60% by 2050, reaching 1.34 million deaths in the US and 184,000 in the UK a sharp increase in drug-resistant bacterial infections is anticipated, which will result in more hospital stays, longer treatment durations, and higher medical cost of treating these infections is already around double that of treating non-resistant the health costs of AMR could rise to $176 billion a year. The UK's annual health bill could surge from $900 million to $3.7 billion, and the US from $15.5 billion to nearly $57 knock-on effect would shrink workforces too: 0.8% in the UK, 0.6% in the EU, and 0.4% in the US. However, the study suggests that investing in solutions, such as developing new antibiotics and improving infection treatment, could deliver substantial economic 2050, the US economy could grow by $156.2 billion annually and the UK by $12 billion if action is Dr. Mohsen Naghavi emphasised that AMR is becoming a bigger threat. Once-treatable illnesses could turn deadly in the absence of immediate, concerted read: Fighting superbugs: New paper-based platform enables rapid antibiotic-resistance screening Policy reforms, the creation of novel medications, and increased public knowledge of the limitations of antibiotics in treating viral infections are all necessary for solutions.A representative representing the UK government reiterated their dedication to combating AMR by developing vaccines, reducing the use of antibiotics in agriculture, and supporting novel treatments. According to the administration, it is still working with other countries to stop the development of antibiotic resistance.

India sends 300,000 Measles and Rubella vaccine doses to Bolivia amid outbreak
India sends 300,000 Measles and Rubella vaccine doses to Bolivia amid outbreak

Time of India

time3 days ago

  • Time of India

India sends 300,000 Measles and Rubella vaccine doses to Bolivia amid outbreak

New Delhi: India on Thursday dispatched a consignment of 300,000 doses of Measles and Rubella vaccines, along with medical supplies, to Bolivia to help the country deal with a growing outbreak of the disease. "India dispatched a consignment of 300,000 doses of Measles & Rubella vaccines along with ancillary supplies to support Bolivia in managing the outbreak of the disease. India stands by its friends in the Global South," Ministry of External Affairs spokesperson Randhir Jaiswal said in a post on X. The shipment arrives at a crucial time as Bolivia has declared a National Health Emergency due to a resurgence of measles cases in several areas. So far, 60 confirmed cases have been reported, according to Xinhua. "After urgently convening the National Strategic Council for Health Emergencies, in response to the measles epidemic that the country is experiencing and the high risk of the disease spreading, we have decided to declare a National Health Emergency with the firm intention of protecting the health and lives of the Bolivian people," Bolivian President Luis Arce Catacora announced on social media, as quoted by Xinhua. The emergency move aims to stop the virus from spreading through mass vaccination efforts and a coordinated response involving local governments, regional bodies, and international organisations. According to Catacora, this step will improve the country's response capacity, activate emergency protocols, and ensure that vaccines are available, especially for children under five. He urged the public to cooperate with health authorities and ensure full immunisation. "Our duty is clear: to protect our children and the entire population from a threat that has already raised health alerts across the continent," he said. Bolivia's Health Minister Maria Renee Castro also expressed concern, stressing the severity of the situation and the risks faced by vulnerable groups. "It is essential that parents get their children vaccinated. The country has 500,000 doses, specifically for girls and boys," Castro said, according to Xinhua. She added that measles is a highly contagious viral illness that can cause serious complications, including pneumonia, encephalitis, or even death, particularly among children with malnutrition or weak immune systems. According to Xinhua, the recent rise in measles cases in Bolivia has been linked to falling vaccination rates, disruptions in healthcare during the COVID-19 pandemic, misinformation, and lack of continuity in prevention programmes. Prime Minister Narendra Modi met Bolivian President Luis Arce Catacora on the sidelines of the BRICS Summit in Rio de Janeiro, where the two leaders reviewed the progress of bilateral cooperation and explored new areas of partnership, especially in the field of critical minerals. According to the Ministry of External Affairs, "The two leaders reviewed bilateral cooperation and expressed satisfaction with the progress achieved." They also discussed collaboration in trade and commerce, Digital Public Infrastructure and UPI, health and pharmaceuticals, traditional medicine, small and medium industries, training, and capacity building. "Both leaders recognized the potential for enhanced collaboration in the critical minerals sector and developing sustainable and mutually beneficial partnerships in the field," the statement said. The MEA noted that both sides "expressed satisfaction over the ongoing development cooperation between the two countries, including through Quick Impact Projects and capacity-building initiatives under the ITEC scholarship programmes." Prime Minister Modi also conveyed India's support for the people of Bolivia following the deadly floods that affected La Paz and other regions earlier this year. "Prime Minister expressed solidarity with the people of Bolivia in the wake of the severe flooding that occurred in March-April 2025 in Laz Paz and several other parts of the country," the MEA said. He further congratulated Bolivia on joining the International Solar Alliance and extended greetings on the upcoming national milestone. "Prime Minister conveyed his warm greetings to the people and Government of Bolivia on the occasion of the country's bicentennial celebration, marking 200 years of independence on 6th August 2025," the statement added. (ANI)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store